• Takeo Kato, Hidenori Sato, Mitsuru Emi, Tomomi Seino, Shigeki Arawaka, Chifumi Iseki, Yoshimi Takahashi, Manabu Wada, and Toru Kawanami.
• Department of Neurology, Hematology, Metabolism, Endocrinology and Diabetology, Yamagata University Faculty of Medicine, Japan. tkato@med.id.yamagata-u.ac.jp
• Intern. Med. 2011 Jan 1; 50 (4): 297303297-303.

ObjectiveIdiopathic normal pressure hydrocephalus (iNPH) is clinically important as a treatable gait disturbance or preventable dementia by shunt operation. We have recently reported that approximately 1.5% of the elderly living in a Japanese community showed ventriculomegaly with features of iNPH on MRI (VIM), which may represent a preclinical stage of iNPH. The purpose of the present study was to identify a possible genetic change in VIM subjects.MethodsEight subjects with VIM and 10 healthy individuals were examined for copy number variations (CNV) with a CNV-targeted whole-genome oligonucleotide microarray (Agilent 400 K CNV array). Another panel of 100 healthy Japanese individuals was screened for CNV by whole-genome using the deCODE-Illumina CNV 370 K chip. Immunohistochemical examination of the human brain was performed using an avidin-biotin-peroxidase complex method.ResultsAmong several genetic changes observed, a copy number loss within the SFMBT1 gene was seen in half of the VIM cases (4 of 8 cases), that was rare among the Japanese control subjects (0/10 by Agilent 400 K CNV array or 1/100 by deCODE/Illumina CNV 370 K chip). Immunohistochemical examination of the human brain revealed that the SFMBT1 protein was localized mainly in the arterial walls, the ependymal cells, and the epithelium of the choroid plexus, all of which play a crucial role in the CSF circulation.ConclusionA segmental copy number loss of the SFMBT1 gene may be involved in the pathological process in some individuals with VIM/iNPH.© 2011 The Japanese Society of Internal Medicine

24 keywords...

hide…